Isolation and Characterization of Human Lung Fibroblasts
Corresponding Organization : Cornell University
Other organizations : California Institute for Regenerative Medicine, Presbyterian Hospital, New York Hospital Queens, NewYork–Presbyterian Hospital
Variable analysis
- MC-EXO (40 μg total protein)
- TGF-β (10 ng/ml)
- TGF-βR1 inhibitor SB525334 (10 μM)
- Lung fibroblast response
- Lung fibroblast cultures were left quiescent for 24 h before treatments
- Cells were pretreated with the inhibitor or vehicle [phosphate-buffered saline (PBS) or ethanol] 15 min before treatment with TGF-β and MC-EXO
- TGF-β (10 ng/ml)
- Vehicle [phosphate-buffered saline (PBS) or ethanol]
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!